Boston Partners’s ICU Medical ICUI Stock Holding History

Boston Partners’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,359	Closed	-$790K	–	750
2024 Q1	$790K	Buy	+7,359	New	+$732K	﹤0.01%	617

Other funds holding ICUI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners's ICUI Position: Q2 2024 in Review

Boston Partners sold out of ICU Medical (ICUI) in Q2 2024, closing a stake of 7,359 shares — an estimated $790K sold.

Boston Partners first reported a position in ICUI in Q1 2024 and held it in 1 quarter. The position peaked at $790K in Q1 2024. 255 funds tracked by Wall St. Rank hold ICUI as of Q2 2024.

Boston Partners reported no remaining ICU Medical position as of Q2 2024 after selling out during the quarter.
Boston Partners sold 7,359 ICU Medical shares in Q2 2024, an estimated $790K.
Boston Partners first reported a position in ICU Medical in Q1 2024 and held it in 1 quarter.
Boston Partners's ICU Medical position peaked at $790K in Q1 2024.
255 funds tracked by Wall St. Rank held ICU Medical as of Q2 2024.

Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.